Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. 2007

Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
Institute of Virology, University of Saarland Medical School, Homburg/Saar D-66421, Germany.

Only few of the human endogenous retrovirus (HERV) sequences in the human genome can produce proteins. We have previously reported that (i) patients with germ cell tumors often make antibodies against proteins encoded by HERV-K elements, (ii) expression of the HERV-K rec gene in transgenic mice can interfere with germ cell development and induce carcinoma in situ, and (iii) HERV-K np9 transcript is overproduced in many tumors including breast cancers. Here we document that both Np9 and Rec physically and functionally interact with the promyelocytic leukemia zinc finger (PLZF) tumor suppressor, a transcriptional repressor and chromatin remodeler implicated in cancer and the self-renewal of spermatogonial stem cells. Interaction is mediated via two different central and C-terminal domains of Np9 and Rec and the C-terminal zinc fingers of PLZF. One major target of PLZF is the c-myc proto-oncogene. Coexpression of Np9 and Rec with PLZF abrogates the transcriptional repression of the c-myc gene promoter by PLZF and results in c-Myc overproduction, altered expression of c-Myc-regulated genes, and corresponding effects on cell proliferation and survival. Thus, the human endogenous retrovirus proteins Np9 and Rec may act oncogenically by derepressing c-myc through the inhibition of PLZF.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075722 Promyelocytic Leukemia Zinc Finger Protein A Kruppel-type transcription factor consisting of an N-terminal BTB DOMAIN and nine CYS2-HIS2 ZINC FINGERS. It localizes to the nucleus and regulates cell cycle progression and gene expression for tissue development and homeostasis; it may also function as an epigenetic regulator through its interactions with HISTONE DEACETYLASE. Genetic rearrangements involving the ZBTB16 gene are associated with ACUTE PROMYELOCYTIC LEUKEMIA. PLZF Protein,Promyelocytic Leukaemia Zinc Finger Protein,ZBTB16 Protein,Zinc Finger and BTB Domain Containing 16 Protein
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D015686 Gene Products, env Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. env Gene Products,env Polyproteins,env Protein,env Antigens,env Glycoproteins,env Polyprotein,Antigens, env,Polyprotein, env,Polyproteins, env
D016335 Zinc Fingers Motifs in DNA- and RNA-binding proteins whose amino acids are folded into a single structural unit around a zinc atom. In the classic zinc finger, one zinc atom is bound to two cysteines and two histidines. In between the cysteines and histidines are 12 residues which form a DNA binding fingertip. By variations in the composition of the sequences in the fingertip and the number and spacing of tandem repeats of the motif, zinc fingers can form a large number of different sequence specific binding sites. Zinc Finger DNA-Binding Domains,Zinc Finger Motifs,Finger, Zinc,Fingers, Zinc,Motif, Zinc Finger,Motifs, Zinc Finger,Zinc Finger,Zinc Finger DNA Binding Domains,Zinc Finger Motif
D051741 Kruppel-Like Transcription Factors A family of zinc finger transcription factors that share homology with Kruppel protein, Drosophila. They contain a highly conserved seven amino acid spacer sequence in between their ZINC FINGER MOTIFS. Kruppel-Like Factor,Kruppel-Like Transcription Factor,Kruppel-Like Factors,Factor, Kruppel-Like,Factor, Kruppel-Like Transcription,Kruppel Like Factor,Kruppel Like Factors,Kruppel Like Transcription Factor,Kruppel Like Transcription Factors,Transcription Factor, Kruppel-Like,Transcription Factors, Kruppel-Like

Related Publications

Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
June 2010, The Journal of general virology,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
September 2000, Oncogene,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
June 2006, Melanoma research,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
March 2024, Journal of medical virology,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
October 2004, Journal of virology,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
January 2014, Leukemia research reports,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
December 2013, Journal of biomedical science,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
April 2024, Viruses,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
October 2009, International journal of cancer,
Miriam Denne, and Marlies Sauter, and Vivienne Armbruester, and Jonathan D Licht, and Klaus Roemer, and Nikolaus Mueller-Lantzsch
January 2012, Frontiers in oncology,
Copied contents to your clipboard!